For ophthalmology practices, drug prices continue to be an issue for patients, and step-therapy and pre-authorization are responses to increasing drug costs. While inflation is less than 2% per year, name brand drug price increases reach double digits year after year, according to George A. Williams, MD, president of the American Academy of Ophthalmology.
Patients who undergo an ophthalmic procedure and are concomitantly taking antithrombotic drugs (antiplatelets and anticoagulants), during the perioperative period may require different management than patients not taking those drugs.
Providing patient-centered care is one component of improving the quality of health care. But this becomes more challenging in pediatric ophthalmology since both the child’s and parents’ perspectives on the eye condition and how it affects their lives have to be considered. The new Pediatric Eye Questionnaires (PedEyeQ) were developed to address this challenge and make outcomes measures more useful.
View the impressive list of delegates already signed up to attend OIS@AAO on October 10th in San Francisco. If you aren’t already on the list, be sure to register:
https://ois.net/ois-aao-2019/oisaao-2019-attendees/
Curated by experts, this Ophthalmology Times clinical resource tackles post-surgery dry eye management, assesses the 2020 pipeline for new treatments, reviews diagnostic tools, and more.
Catch up now.
ADVERTISEMENT
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
https://ois.net/ois-aao-2019/oisaao-2019-attendees/
Catch up now.
